Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Mark Biagi"'
Autor:
Nicholas Rebold, Sara Alosaimy, Jeffrey C. Pearson, Brandon Dionne, Ahmad Taqi, Abdalhamid Lagnf, Kristen Lucas, Mark Biagi, Nicholas Lombardo, Joshua Eudy, Daniel T. Anderson, Monica V. Mahoney, Wesley D. Kufel, Joseph A. D’Antonio, Bruce M. Jones, Jeremy J. Frens, Tyler Baumeister, Matthew Geriak, George Sakoulas, Dimitrios Farmakiotis, Dino Delaportas, Jeremy Larew, Michael P. Veve, Michael J. Rybak
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 3, Pp 565-579 (2024)
Abstract Introduction Long-acting lipoglycopeptides such as dalbavancin may have utility in patients with Gram-positive bloodstream infections (BSI), particularly in those with barriers to discharge or who require prolonged parenteral antibiotic cour
Externí odkaz:
https://doaj.org/article/329fe8cb8de8423a9b5e528288ac79f6
Autor:
Ashlan J. Kunz Coyne, Sara Alosaimy, Kristen Lucas, Abdalhamid M. Lagnf, Taylor Morrisette, Kyle C. Molina, Alaina DeKerlegand, Melanie Rae Schrack, S. Lena Kang-Birken, Athena L.V. Hobbs, Jazmin Agee, Nicholson B. Perkins, Mark Biagi, Michael Pierce, James Truong, Justin Andrade, Jeannette Bouchard, Tristan Gore, Madeline A. King, Benjamin M. Pullinger, Kimberly C. Claeys, Shelbye Herbin, Reese Cosimi, Serina Tart, Michael P. Veve, Bruce M. Jones, Leonor M. Rojas, Amy K. Feehan, Marco R. Scipione, Jing J. Zhao, Paige Witucki, Michael J. Rybak
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 1 (2024)
ABSTRACT Eravacycline is a synthetic fluorocycline approved by the U.S. Food and Drug Administration in 2018. This study aimed to describe clinical and microbiological outcomes in addition to associated adverse effects of eravacycline used in U.S. ho
Externí odkaz:
https://doaj.org/article/c7670c6ad2ab4a279e5ee3917f0e0369
Autor:
Sara Alosaimy, Taylor Morrisette, Abdalhamid M. Lagnf, Leonor M. Rojas, Madeline A. King, Benjamin M. Pullinger, Athena L. V. Hobbs, Nicholson B. Perkins, Michael P. Veve, Jeannette Bouchard, Tristan Gore, Bruce Jones, James Truong, Justin Andrade, Glen Huang, Reese Cosimi, S. Lena Kang-Birken, Kyle C. Molina, Mark Biagi, Michael Pierce, Marco R. Scipione, Jing J. Zhao, Susan L. Davis, Michael J. Rybak
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 5 (2022)
ABSTRACT Forty-six patients were treated with eravacycline (ERV) for Acinetobacter baumannii infections, where 69.5% of isolates were carbapenem resistant (CRAB). Infections were primarily pulmonary (58.3%), and most patients received combination the
Externí odkaz:
https://doaj.org/article/3784b810c9054f3dafb994059224b8c7
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 3 (2022)
ABSTRACT Tetracycline-based combinations are increasingly used for serious carbapenem-nonsusceptible Acinetobacter baumannii (CNSAb) infections given their potent in vitro activity, synergism with other agents, and acceptable toxicity profile. Omadac
Externí odkaz:
https://doaj.org/article/685d9d92ed6644e3ba548123e824a652
Publikováno v:
Antibiotics, Vol 11, Iss 9, p 1200 (2022)
Bordetella bronchiseptica infections may be overlooked by clinicians due to the uncommon encounter of this pathogen in humans and common isolation of co-pathogens. However, the isolation of B. bronchiseptica in immunocompromised individuals may repre
Externí odkaz:
https://doaj.org/article/49225024fb9a45c480a6a68f09a82fcc
Publikováno v:
Antibiotics, Vol 8, Iss 1, p 27 (2019)
Despite advancements in therapy, pneumonia remains the leading cause of death due to infectious diseases. Novel treatment strategies are desperately needed to optimize the antimicrobial therapy of patients suffering from this disease. One such strate
Externí odkaz:
https://doaj.org/article/64513ed6b43e49189feddf46f7677ac7
Publikováno v:
Microbiology spectrum. 10(4)
Stenotrophomonas maltophilia most often infects the lungs, where the physiologic environment is naturally slightly acidic (pH ~6.6), compared to most parts of the body (such as the bloodstream), which have neutral pH values (~7.4). Pneumonia due to S
Autor:
Sara Alosaimy, Abdalhamid M Lagnf, Athena L V Hobbs, Musa Mubarez, Wesley D Kufel, Taylor Morrisette, Radhika S Polisetty, David Li, Michael P Veve, Sam P Simon, James Truong, Natalie Finch, Veena Venugopalan, Matthew Rico, Lee Amaya, Christine Yost, Ashley Cubillos, Elisabeth Chandler, Megan Patch, Ian Murphy Kelsey Smith, Mark Biagi, Justin Wrin, W Justin Moore, Kyle C Molina, Nicholas Rebold, Dana Holger, Ashlan J Kunz Coyne, Sarah C J Jorgensen, Paige Witucki, Nikki N Tran, Susan L Davis, George Sakoulas, Michael J Rybak
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Background Vancomycin (VAN)-associated acute kidney injury (AKI) is increased when VAN is combined with certain beta-lactams (BLs) such as piperacillin-tazobactam (TZP) but has not been evaluated with ceftolozane-tazobactam (C/T). Our aim was to inve
Autor:
Nicholas Rebold, Taylor Morrisette, Abdalhamid M Lagnf, Sara Alosaimy, Dana Holger, Katie Barber, Julie Ann Justo, Kayla Antosz, Travis J Carlson, Jeremy J Frens, Mark Biagi, Wesley D Kufel, William J Moore, Nicholas Mercuro, Brian R Raux, Michael J Rybak
Publikováno v:
Open Forum Infectious Diseases
A multicenter case series of 21 patients were treated with imipenem-cilastatin-relebactam. There were mixed infection sources, with pulmonary infections (11/21,52%) composing the majority. The primary pathogen was Pseudomonas aeruginosa (16/21, 76%),
Publikováno v:
International Journal of STD & AIDS. 32:89-91
Metronidazole desensitization is recommended in patients with trichomoniasis and history of an allergic reaction to metronidazole due to presumed cross reactivity with tinidazole and lack of reliably safe and effective alternative therapies. We repor